BAFNA PHARMACEUTICALS
Back to Balance Sheet
|
BAFNA PHARMACEUTICALS Last 5 Year Total Non-Current Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹16 Cr | ₹13 Cr | ₹9.65 Cr | ₹6.17 Cr | ₹5.39 Cr |
What is the latest Total Non-Current Liabilities ratio of BAFNA PHARMACEUTICALS ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹16 Cr |
| Mar2024 | ₹13 Cr |
| Mar2023 | ₹9.65 Cr |
| Mar2022 | ₹6.17 Cr |
| Mar2021 | ₹5.39 Cr |
How is Total Non-Current Liabilities of BAFNA PHARMACEUTICALS Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹16 Cr | 28.69 | |
| Mar2024 | ₹13 Cr | 32.20 | |
| Mar2023 | ₹9.65 Cr | 56.49 | |
| Mar2022 | ₹6.17 Cr | 14.52 | |
| Mar2021 | ₹5.39 Cr | - | |
Compare Total Non-Current Liabilities of peers of BAFNA PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BAFNA PHARMACEUTICALS | ₹687.8 Cr | 6.2% | 42.6% | 227.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹467,630.0 Cr | -0.1% | 0.5% | 14% | Stock Analytics | |
| DIVIS LABORATORIES | ₹218,972.0 Cr | -0.9% | 21.1% | 25.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹188,358.0 Cr | -1.3% | 1.1% | 32.7% | Stock Analytics | |
| CIPLA | ₹118,916.0 Cr | 0.2% | 2.1% | -5.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,824.0 Cr | 0.2% | -7.7% | -7.5% | Stock Analytics | |
BAFNA PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BAFNA PHARMACEUTICALS | 6.2% |
42.6% |
227.9% |
| SENSEX | 0.5% |
2.6% |
-3.7% |
You may also like the below Video Courses